Patients with immunocompromising conditions are at higher risk of vaccine-preventable infections. Further, those receiving immunosuppressive disease-modifying antirheumatic drugs (DMARDs) can have variable responses to vaccines depending on which vaccine and which DMARD they are receiving.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Day, A. L., Winthrop, K. L., & Curtis, J. R. (2020). The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults. Cleveland Clinic Journal of Medicine, 87(11), 695–703. https://doi.org/10.3949/ccjm.87a.20056